Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.75 - $3.96 $48,912 - $110,682
27,950 New
27,950 $63,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $9,965 - $24,058
-3,225 Reduced 10.34%
27,950 $88,000
Q2 2022

Aug 15, 2022

SELL
$1.92 - $6.28 $334,051 - $1.09 Million
-173,985 Reduced 84.8%
31,175 $86,000
Q1 2022

May 11, 2022

BUY
$5.07 - $7.2 $30,105 - $42,753
5,938 Added 2.98%
205,160 $1.23 Million
Q4 2021

Feb 11, 2022

SELL
$5.67 - $8.54 $24,329 - $36,645
-4,291 Reduced 2.11%
199,222 $1.28 Million
Q3 2021

Nov 12, 2021

BUY
$13.4 - $16.3 $170,783 - $207,743
12,745 Added 6.68%
203,513 $2.81 Million
Q2 2021

Aug 11, 2021

SELL
$14.81 - $19.13 $533,870 - $689,598
-36,048 Reduced 15.89%
190,768 $2.83 Million
Q1 2021

May 13, 2021

SELL
$14.52 - $23.53 $171,321 - $277,630
-11,799 Reduced 4.94%
226,816 $4.04 Million
Q4 2020

Feb 09, 2021

BUY
$10.14 - $15.19 $42,770 - $64,071
4,218 Added 1.8%
238,615 $3.41 Million
Q3 2020

Nov 12, 2020

BUY
$9.57 - $21.32 $69,755 - $155,401
7,289 Added 3.21%
234,397 $2.37 Million
Q2 2020

Aug 12, 2020

BUY
$12.21 - $16.99 $31,697 - $44,106
2,596 Added 1.16%
227,108 $3.34 Million
Q1 2020

May 06, 2020

BUY
$9.03 - $19.72 $123,096 - $268,823
13,632 Added 6.46%
224,512 $3 Million
Q4 2019

Feb 14, 2020

BUY
$13.01 - $17.15 $79,361 - $104,614
6,100 Added 2.98%
210,880 $2.97 Million
Q3 2019

Nov 07, 2019

SELL
$14.55 - $20.56 $89,744 - $126,814
-6,168 Reduced 2.92%
204,780 $3.34 Million
Q2 2019

Aug 12, 2019

SELL
$15.0 - $19.62 $46,845 - $61,273
-3,123 Reduced 1.46%
210,948 $3.31 Million
Q1 2019

May 14, 2019

SELL
$11.65 - $17.72 $10,298 - $15,664
-884 Reduced 0.41%
214,071 $3.72 Million
Q4 2018

Feb 11, 2019

BUY
$10.72 - $16.73 $8,758 - $13,668
817 Added 0.38%
214,955 $2.39 Million
Q3 2018

Nov 09, 2018

SELL
$17.73 - $26.69 $8,776 - $13,211
-495 Reduced 0.23%
214,138 $0
Q2 2018

Aug 06, 2018

SELL
$10.79 - $24.44 $28,625 - $64,839
-2,653 Reduced 1.22%
214,633 $3.89 Million
Q1 2018

May 15, 2018

SELL
$9.0 - $20.16 $1,125 - $2,520
-125 Reduced 0.06%
217,286 $2.43 Million
Q4 2017

Feb 09, 2018

BUY
$13.26 - $22.86 $2.88 Million - $4.97 Million
217,411
217,411 $4.22 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $684M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.